Azenta Life Sciences’ Post

View organization page for Azenta Life Sciences, graphic

65,603 followers

Curious about how distribution models and cold chain management impact product quality for cell and gene therapies? Check out this interview with Azenta’s own David Lewandowski, Director of Business Development for Automated Storage, discussing the hot topic of regulatory challenges for cell and gene therapy manufacturers. It’s part of a collaborative series with Phacilitate and Germfree. #coldchain #CGT #cellandgenetherapies #phacilitate

View organization page for Germfree, graphic

4,356 followers

NOW LIVE! CGT Insights: Episode 2 - "Regulatory Challenges: Product Quality (CMC) Challenges and Opportunities" In the second episode of our collaborative series with Phacilitate, join Carol Houts, Chief Strategy Officer at Germfree, and David Lewandowski, Director of Business Development at Azenta Life Sciences, for a concise yet insightful exploration of the complex landscape surrounding patient access, compressed timelines, and regulatory dynamics in the realm of cell and gene therapies. Watch it now! ➡️ https://hubs.ly/Q01_b-950 #CGTInsights #CGT #celleandgenetherapy

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics